Clinical infectious diseases, 2009-11, Vol.49 (9), p.1397-1401
2009
Details
- Autor(en) / Beteiligte
- Titel
- Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients
- Ist Teil von
- Clinical infectious diseases, 2009-11, Vol.49 (9), p.1397-1401
- Ort / Verlag
- Oxford: University of Chicago Press
- Erscheinungsjahr
- 2009
- Link zum Volltext
- Quelle
- Oxford Journals 2020 Medicine
- Beschreibungen/Notizen
- Information on the rate and timing of hepatitis C virus (HCV) relapse after treatment with pegylated interferon plus ribavirin is scarce. Among 604 patients treated for chronic hepatitis C, the 386 who were human immunodeficiency virus (HIV) positive attained an end-of-treatment response less frequently and experienced relapse more often than did the 218 who were HIV negative. However, episodes of HCV relapse occurred before week 12 in most cases, regardless of HIV status.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1058-4838eISSN: 1537-6591DOI: 10.1086/630205Titel-ID: cdi_proquest_miscellaneous_754546073
- Format
- –
- Schlagworte
- Adult, Antibiotics. Antiinfectious agents. Antiparasitic agents, Antiviral agents, Antiviral Agents - therapeutic use, Biological and medical sciences, BRIEF REPORTS, Chronic hepatitis, Female, Genotypes, Hepacivirus, Hepacivirus - drug effects, Hepacivirus - pathogenicity, Hepatitis, Hepatitis C, Hepatitis C - drug therapy, Hepatitis C virus, HIV, HIV Infections - drug therapy, Human immunodeficiency virus, Human viral diseases, Humans, Infectious diseases, Information, Interferon, Interferon-alpha - therapeutic use, Interferons, Male, Medical sciences, Medical treatment, Middle Aged, Pharmacology. Drug treatments, Polyethylene Glycols - therapeutic use, Recombinant Proteins, Relapse, Ribavirin - therapeutic use, RNA, Treatment Outcome, Viral diseases, Viral diseases of the lymphoid tissue and the blood. Aids, Viral hepatitis, Virology, Viruses